THE CONTENT OF THIS WEBINAR IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT INTENDED TO CONVEY LEGAL OR OTHER PROFESSIONAL ADVICE.
As an evolving regulatory agency, the National Health Surveillance Agency, ANVISA, is continually introducing updates and innovations to Brazil’s medical device regulations. Staying informed is critical to maintaining compliance and successful market access.
Webinar date
June 25, 2025
Speakers
Luiz Levy, RAC, manager, Quality and Regulatory Affairs
Lilian Pinheiro, lead quality and regulatory affairs consultant
Our experts will walk through key changes shaping Brazil’s regulatory landscape.
In this session, our presenters will cover:
Recent updates from ANVISA’s 2024-2025 regulatory agenda, including the status of current and upcoming regulations under development and their expected impact on the market.
Unique Device Identification (UDI) requirements, including marking rules, the ANVISA UDI system and the compliance deadline in Brazil.
Our team will outline the responsibilities for entities that must submit UDI information and should be in place by July 2025 for medical devices.
Attend an upcoming webinar
Ready to elevate your industry IQ with insights and news from experts? Register for one of our upcoming events.
X
Request more information from our specialists
Thanks for your interest in our products and services. Let's collect some information so we can connect you with the right person.
Please wait…